Cefpodoxime labels and packages

Revision as of 17:07, 6 January 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Cefpodoxime}} {{CMG}};{{AE}}{{AK}} '''Rx only''' Licensed from Sankyo Company, Ltd., Japan image:Pfizer.jpg LAB-0035-5.0 April 2007 '''PRINCIPAL DISPLAY P...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cefpodoxime Proxetil
VANTIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Rx only Licensed from Sankyo Company, Ltd., Japan

LAB-0035-5.0

April 2007

PRINCIPAL DISPLAY PANEL - 200 mg Tablet Bottle Label

6505-01-368-2870

Vantin® cefpodoxime proxetil tablets, USP

200 mg

100 Tablets


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050674s015,050675s018lbl.pdf

Retrieved from "https://www.wikidoc.org/index.php?title=Cefpodoxime_labels_and_packages&oldid=926226"